eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
advertisement
.
..activity.
. tusk made his remarks about the u.s. president's reliability before he chaired a meeting in bulgaria of the 28 leaders whose countries make up the world's biggest trading bloc..